Fact CheckerSign in

NCT07000474Active, not recruiting

Multiparametric Characterization of Colorectal Cancers (METRAD)

Multiparametric Characterization of Colorectal Cancers

Source: ClinicalTrials.gov · Last updated 3 Jun 2025

Brief summary (registry, in English)

The primary goal of this observational study is to assess the predictive value of a model developed through a multiparametric analysis of clinical images, histopathological data, CT scans, and molecular analysis. This analysis will be conducted on a retrospective cohort recruited at CHU Brest (training group). The model will then be validated using external cohorts from other centers (test group).

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
20 May 2025
Start date
1 Mar 2025
Primary completion date
31 Dec 2026
Lead sponsor
University Hospital, Brest
NCT number
NCT07000474

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 1 Mar 2025 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals with conditions that could interfere with the study protocol or impact data integrity

Other

  • Patients under legal protection (guardianship, curatorship, etc.)
  • Refusal to participate (expressed opposition)

Who the study is looking for

  • Patients who have undergone surgery for colorectal cancer.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chu Brest
Coordinator of this site? Confirm its status
BrestFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.